Adial Pharmaceuticals, Inc.
ADIL
$1.97
$0.147.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.85% | 8.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.88% | -6.30% | |||
| Operating Income | -6.88% | 6.30% | |||
| Income Before Tax | -11.29% | 8.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.29% | 8.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.29% | 8.42% | |||
| EBIT | -6.88% | 6.30% | |||
| EBITDA | -6.88% | 6.31% | |||
| EPS Basic | 9.78% | 56.12% | |||
| Normalized Basic EPS | 9.79% | 56.12% | |||
| EPS Diluted | 9.78% | 56.12% | |||
| Normalized Diluted EPS | 9.79% | 56.12% | |||
| Average Basic Shares Outstanding | 23.35% | 108.73% | |||
| Average Diluted Shares Outstanding | 23.35% | 108.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||